Olverembatinib
Olverembatinib (GZD 824) is an orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT, IC50: 0.34 nM) and Bcr-Abl(T315I, IC50: 0.68 nM).
| Catalog Number | T3071 |
| Alternative Name(s) | GZD 824 |
| Research Area | Tyrosine Kinase/Adaptors|||Cytoskeletal Signaling|||Angiogenesis |
| Molecular Formula | C29H27F3N6O |
| CAS# | 1257628-77-5 |
| Purity | 99.29% |
| SMILES | CN1CCN(Cc2c(cc(NC(=O)c3cc(C#Cc4cc5c([nH]nc5)nc4)c(C)cc3)cc2)C(F)(F)F)CC1 |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Olverembatinib |
| Additional Information | https://www.targetmol.com/datasheet/T3071 |